There are 3 papers on aMAP score in aging research: 3 observational studies in people.
3 papers study it4 findings
1 new paper in 30 daysSee all 3
“The aMAP score showed favourable discrimination (C-indices: 0.80 [95% CI, 0.78-0.83] in UKB; 0.79 [95% CI, 0.73-0.85] in the Chinese cohort).”
- Humans3
Associations
2Hepatocellular carcinoma
upin humans2
2 studies
Hepatocellular carcinoma
upin humans2
aMAP score predicts hepatocellular carcinoma in humans (Steatotic liver disease; UK Biobank) (C-index 0.80, 95% CI 0.78–0.83).
“The aMAP score showed favourable discrimination (C-indices: 0.80 [95% CI, 0.78-0.83] in UKB; 0.79 [95% CI, 0.73-0.85] in the Chinese cohort).”
HumansSteatotic liver disease; UK BiobankMedian follow-up of 13.64 yearsn = 156,406
Liver international : official journal of the International Association for the Study of the Liver
aMAP score is associated with hepatocellular carcinoma in chronic hepatitis surveillance (0.98, 7.05 and 29.1 events per 1000 person-years).
“The HCC incidence rate was 0.98, 7.05 and 29.1 events per 1000 person-years in the low-, moderate- and high-risk aMAP groups, respectively.”
Humansin chronic hepatitis surveillancen = 3,473
British journal of cancer
aMAP score predicts hepatocellular carcinoma in humans (chronic hepatitis surveillance) (C-index 0.81 (95% CI: 0.79-0.82)).
“The aMAP score achieved an overall C-index of 0.81 (95% CI: 0.79-0.82) consistent with the initial report and was unaffected by allowance for competing causes of death.”
Humanschronic hepatitis surveillancen = 3,473
British journal of cancer
Hepatocellular carcinoma incidence
upin humans1
1 study
Hepatocellular carcinoma incidence
upin humans1
aMAP score is associated with hepatocellular carcinoma incidence in humans (Steatotic liver disease in UK Biobank; high-risk versus low-risk aMAP groups) (High versus low risk: sHR 28.51, 95% CI 19.58–41.52; 15-year incidence 1.43% versus 0.06%).
“for low-, intermediate- and high-risk groups (high vs. low risk, sHR: 28.51; 95% CI, 19.58-41.52; Gray's test p < 0.001).”
HumansSteatotic liver disease in UK Biobank; high-risk versus low-risk aMAP groups15 yearsn = 156,406
Liver international : official journal of the International Association for the Study of the Liver